Volume 149, Issue 6, Pages (November 2015)

Slides:



Advertisements
Similar presentations
Efficacy and Safety of Ledipasvir/Sofosbuvir with and without Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: a meta-analysis 
Advertisements

Rapid virological response tailors the duration of treatment in hepatitis C virus genotype 3 patients treated with pegylated interferon alfa-2a and ribavirin.
Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen?  Patrick Marcellin, E. Jenny Heathcote,
Volume 139, Issue 4, Pages (October 2010)
Volume 139, Issue 5, Pages e1 (November 2010)
Volume 151, Issue 5, Pages (November 2016)
Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
Covering the Cover Gastroenterology
Volume 149, Issue 6, Pages (November 2015)
Identification of the Best Direct-Acting Antiviral Regimen for Patients With Hepatitis C Virus Genotype 3 Infection: A Systematic Review and Network Meta-analysis 
New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges
Volume 139, Issue 4, Pages (October 2010)
Effectiveness of Hepatitis B Treatment in Clinical Practice
Volume 153, Issue 4, Pages (October 2017)
Is HCV Infection a Neurologic Disorder?
Volume 146, Issue 3, Pages e1 (March 2014)
Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection  Tobias Boettler, Robert Thimme  Gastroenterology 
Volume 143, Issue 3, Pages e5 (September 2012)
Peginterferon alfa-2b plus ribavirin for chronic hepatitis
Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin  Jean–François Rossignol, Asem Elfert,
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 149, Issue 4, Pages e1 (October 2015)
Volume 151, Issue 4, Pages e1 (October 2016)
Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
Volume 135, Issue 4, Pages (October 2008)
Volume 133, Issue 5, Pages (November 2007)
Fasiha Kanwal, MD, MSHS, Hashem B. El-Serag, MD, MPH 
Volume 150, Issue 4, Pages (April 2016)
Volume 146, Issue 3, Pages e3 (March 2014)
Volume 154, Issue 4, Pages (March 2018)
Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse 
Yasuhiko Sugawara, Masatoshi Makuuchi 
Volume 155, Issue 5, Pages e2 (November 2018)
Jean-Michel Pawlotsky  Gastroenterology 
Volume 136, Issue 2, Pages e3 (February 2009)
Volume 138, Issue 1, Pages (January 2010)
Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H
The Combination of Simeprevir and Sofosbuvir Is More Effective Than That of Peginterferon, Ribavirin, and Sofosbuvir for Patients With Hepatitis C–Related.
Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection  Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco.
Safety and Antiviral Activity of Albinterferon Alfa-2b Dosed Every Four Weeks in Genotype 2/3 Chronic Hepatitis C Patients  Vincent G. Bain, Kelly D.
Volume 142, Issue 6, Pages (May 2012)
Volume 139, Issue 4, Pages e4 (October 2010)
Volume 138, Issue 7, Pages (June 2010)
Volume 151, Issue 5, Pages e1 (November 2016)
Rafael Esteban, Maria Buti  Gastroenterology 
Volume 140, Issue 7, Pages (June 2011)
Brendan Campbell, Benny Liu, Taft Bhuket, Robert J. Wong 
Volume 133, Issue 2, Pages (August 2007)
Volume 145, Issue 4, Pages e3 (October 2013)
Covering the Cover Gastroenterology
Volume 148, Issue 3, Pages (March 2015)
Genetic Factors and Hepatitis C Virus Infection
Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C  Gowtham A. Rao, Prashant K. Pandya  Gastroenterology 
Volume 143, Issue 3, Pages e5 (September 2012)
Alessio Aghemo, Maria Francesca Donato  Gastroenterology 
Hepatitis C treatment in patients with kidney disease
Covering the Cover Gastroenterology
Volume 147, Issue 2, Pages e1 (August 2014)
Volume 150, Issue 7, Pages (June 2016)
Meta-analysis Shows Extended Therapy Improves Response of Patients With Chronic Hepatitis C Virus Genotype 1 Infection  Harald Farnik, Christian M. Lange,
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 139, Issue 5, Pages (November 2010)
Volume 147, Issue 6, Pages (December 2014)
Detection of HCV RNA in Sustained Virologic Response to Direct-Acting Antiviral Agents: Occult or Science Fiction?  Masaru Enomoto, Yoshiki Murakami,
Electronic Clinical Challenges and Images in GI
Volume 62, Issue 5, Pages (May 2015)
The Results of Phase III Clinical Trials With Telaprevir and Boceprevir Presented at the Liver Meeting 2010: A New Standard of Care for Hepatitis C Virus.
Volume 148, Issue 1, Pages (January 2015)
Induction Pegylated Interferon Alfa-2b in Combination With Ribavirin in Patients With Genotypes 1 and 4 Chronic Hepatitis C: A Prospective, Randomized,
Fasiha Kanwal, Tuyen Hoang, Timothy Chrusciel, Jennifer R
Presentation transcript:

Volume 149, Issue 6, Pages 1462-1470 (November 2015) Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-Alfa in Patients With Hepatitis C Virus Genotype 3 Infection and Treatment-Experienced Patients With Cirrhosis and Hepatitis C Virus Genotype 2 Infection  Graham R. Foster, Stephen Pianko, Ashley Brown, Daniel Forton, Ronald G. Nahass, Jacob George, Eleanor Barnes, Diana M. Brainard, Benedetta Massetto, Ming Lin, Bin Han, John G. McHutchison, G. Mani Subramanian, Curtis Cooper, Kosh Agarwal  Gastroenterology  Volume 149, Issue 6, Pages 1462-1470 (November 2015) DOI: 10.1053/j.gastro.2015.07.043 Copyright © 2015 AGA Institute Terms and Conditions

Figure 1 Rates of SVR12 by subgroup in patients with genotype 3 HCV. The position of the squares indicates the rate of virologic response 12 weeks after the end of treatment in the subgroup. Horizontal lines indicate 95% confidence intervals. Vertical lines represent the overall rates of SVR. Gastroenterology 2015 149, 1462-1470DOI: (10.1053/j.gastro.2015.07.043) Copyright © 2015 AGA Institute Terms and Conditions